Delgocitinib topical Interactions
There are 256 drugs known to interact with delgocitinib topical. Of the total drug interactions, 20 are major, and 236 are moderate.
Medications known to interact with delgocitinib topical
Note: Showing generic names only.
A
- abatacept
- abrocitinib
- adalimumab
- adenovirus vaccine
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- anthrax vaccine adsorbed
- anti-thymocyte globulin (rabbit)
- asciminib
- atezolizumab
- avacopan
- avelumab
- axicabtagene ciloleucel
- azathioprine
B
- baricitinib
- basiliximab
- bcg
- bcg vaccine
- belatacept
- belimumab
- belumosudil
- benralizumab
- bifidobacterium infantis
- bifidobacterium longum
- bimekizumab
- blinatumomab
- brewer's yeast
- brexucabtagene autoleucel
- brodalumab
C
- canakinumab
- candida albicans extract
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- cholera vaccine
- cholera vaccine, live
- ciltacabtagene autoleucel
- cladribine
- coccidioidin skin test
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizotinib
- crovalimab
- cyclosporine
D
- daclizumab
- danicopan
- dasatinib
- dengue vaccine
- denosumab
- deucravacitinib
- deuruxolitinib
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- dupilumab
- durvalumab
- duvelisib
E
- eculizumab
- efalizumab
- efgartigimod alfa
- elranatamab
- emapalumab
- epcoritamab
- etanercept
- etrasimod
- everolimus
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
I
- ibritumomab
- idecabtagene vicleucel
- idelalisib
- imatinib
- inebilizumab
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- iodine i 131 tositumomab
- ipilimumab
- iptacopan
- ixekizumab
J
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lebrikizumab
- leflunomide
- lenalidomide
- linvoseltamab
- lisocabtagene maraleucel
- loncastuximab tesirine
- lyme disease vaccine
- lymphocyte immune globulin, anti-thy (equine)
M
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group acwy conjugate-group b vaccine (cvx 328)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mepolizumab
- mercaptopurine
- methotrexate
- mirikizumab
- mixed respiratory vaccine
- momelotinib
- monomethyl fumarate
- mosunetuzumab
- mumps skin test antigen
- mumps virus vaccine
- muromonab-cd3
- mycophenolate mofetil
- mycophenolic acid
N
O
P
- pacritinib
- palbociclib
- pegcetacoplan
- pembrolizumab
- penpulimab
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- pomalidomide
- ponesimod
- pozelimab
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- ravulizumab
- reslizumab
- retifanlimab
- ribociclib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- roflumilast
- rotavirus vaccine
- rozanolixizumab
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- rucaparib
- ruxolitinib
S
- saccharomyces boulardii lyo
- sarilumab
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) nvx-cov2705 vaccine, adjuvanted
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- satralizumab
- secukinumab
- siltuximab
- siponimod
- sipuleucel-T
- sirolimus
- sirolimus protein-bound
- sirolimus topical
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- spesolimab
- staphage lysate (spl)
- streptococcus salivarius
T
- tacrolimus
- tacrolimus topical
- talimogene laherparepvec
- talquetamab
- tarlatamab
- tebentafusp
- teclistamab
- temsirolimus
- teriflunomide
- tetanus toxoid
- tezepelumab
- thalidomide
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tildrakizumab
- tisagenlecleucel
- tislelizumab
- tocilizumab
- tofacitinib
- toripalimab
- tositumomab
- tralokinumab
- tremelimumab
- trichophyton skin test
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
Y
Z
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.